SequelSEC

AiXin Life International, Inc. AIXN

Retail-Drug Stores and Proprietary Stores · CIK 0000835662 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$1.13M
Fiscal year ended 2025-12-31
Operating income
-$2.52M
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$883.72KMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.04Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue1.3×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

AiXin Life International, Inc. (AIXN) reported revenue of $1.13M and net income of -$2.04M for the fiscal year ended 2025-12-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from AiXin Life International, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Retail-Drug Stores and Proprietary Stores.

Income

AiXin Life International, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-31
Revenue$1.13M
Cost of revenue$867.82K
Gross profit$262.38K
Operating income-$2.52M
Net income-$2.04M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$2.04M
Income tax expense$391
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$1.55M
Selling & marketingUnavailable

Balance

AiXin Life International, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-31
Cash & equivalents$20.75K
Total assets$3.20M
Current assets$1.02M
Total liabilities$9.77M
Current liabilities$8.49M
Total equity incl. NCI-$6.57M
Temporary (mezzanine) equityUnavailable
Inventory$427.43K
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

AiXin Life International, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-31
Operating cash flow-$2.03M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$1.99M
Net change in cash-$41.56K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$156.83K

Derived

AiXin Life International, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-31
Free cash flowUnavailable
Gross margin23.2%
Operating margin-223.0%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.12x
Revenue YoY growth-29.3%
Net margin-180.7%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AIXN in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-05-15View SEC filing
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-20View SEC filing
10-Q · Filed 2025-06-27View SEC filing
10-K · Filed 2025-05-07View SEC filing
10-Q · Filed 2024-12-27View SEC filing

Companies in the same industry

CVS GRDN PETS

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.